Combined inhibition of topoisomerases I and II - is this a worthwhile/feasible strategy?
Open Access
- 1 December 1997
- journal article
- Published by Springer Nature in British Journal of Cancer
- Vol. 76 (11) , 1395-1397
- https://doi.org/10.1038/bjc.1997.568
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Sequential administration of camptothecin and etoposide circumvents the antagonistic cytotoxicity of simultaneous drug administration in slowly growing human colon carcinoma HT-29 cellsEuropean Journal Of Cancer, 1992
- Experimental studies on biochemical modulation targeting topoisomerase I and II in human tumor xenografts in nude miceInternational Journal of Cancer, 1992
- Effects of CPT‐11 in combination with other anti‐cancer agents in cultureInternational Journal of Cancer, 1992
- Study of molecular markers of resistance to m-AMSA in a human breast cancer cell line: Decrease of topoisomerase II and increase of both topoisomerase I and acidic glutathione S transferaseBiochemical Pharmacology, 1991
- The S-phase cytotoxicity of camptothecinExperimental Cell Research, 1991
- DNA Topoisomerase I—Targeted Chemotherapy of Human Colon Cancer in XenograftsScience, 1989
- Nonproductive Rearrangement of DNA Topoisomerase I and II Genes: Correlation With Resistance to Topoisomerase InhibitorsJNCI Journal of the National Cancer Institute, 1989
- Unknotting the Complexities of Multidrug Resistance: The Involvement of DNA Topoisomerases in Drug Action and ResistanceJNCI Journal of the National Cancer Institute, 1989
- Multidrug Resistance1JNCI Journal of the National Cancer Institute, 1988
- Adriamycin-Induced DNA Damage Mediated by Mammalian DNA Topoisomerase IIScience, 1984